UNITED STATES NEWS

Pfizer asks US officials to OK promising COVID-19 pill

Nov 16, 2021, 5:00 PM | Updated: Nov 17, 2021, 11:24 am

WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

The company’s filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.

Pfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,” said Pfizer CEO Albert Bourla, in a statement.

Specifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That’s similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.

The FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.

Some experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren’t part of the initial tests.

For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.

Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That’s different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can’t reproduce itself.

On Tuesday, Pfizer signed a deal a with U.N.-backed group to allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.

The U.S. government has already committed to purchasing Merck’s pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.

___

AP reporter Zeke Miller in Washington contributed.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Lifetime Windows & Doors

United States News

Associated Press

Marshawn Lynch, ex-NFL, booked on suspicion of DUI in Vegas

LAS VEGAS (AP) — Former NFL running back Marshawn Lynch was arrested Tuesday in Las Vegas on suspicion of driving impaired, according to police. Officers stopped the vehicle that Lynch, 36, was driving at about 7:30 a.m., concluded that he was impaired and detained him, police said in a statement. Lynch was booked into the […]
14 hours ago
FILE - A man holds a sign urging increased access to the monkeypox vaccine during a protest in San ...
Associated Press

US will stretch monkeypox vaccine supply with smaller doses

WASHINGTON (AP) — U.S. health officials on Tuesday authorized a plan to stretch the nation’s limited supply of monkeypox vaccine by giving people just one-fifth the usual dose, citing research suggesting that the reduced amount is about as effective. The so-called dose-sparing approach also calls for administering the Jynneos vaccine with an injection just under […]
14 hours ago
FILE - Serena Williams holds the championship trophy after beating Victoria Azarenka, of Belarus, i...
Associated Press

AP PHOTOS: Serena Williams, the athlete and cultural icon

After winning 23 Grand Slam titles, Serena Williams says she is turning her focus to having another child and her business interests as she readies to step away from tennis. “I’m turning 41 this month, and something’s got to give,” Williams wrote in an essay released Tuesday by Vogue magazine, and a post on Instagram. […]
14 hours ago
In this photo provided by the University of Arizona and U.S. Fish and Wildlife Service shows a male...
Associated Press

‘El Jefe’ the jaguar, famed in US, photographed in Mexico

MEXICO CITY (AP) — They call him “El Jefe,” he is at least 12 years old and his crossing of the heavily guarded U.S.-Mexico border has sparked celebrations on both sides. “El Jefe” — or “The Boss” — is one of the oldest jaguars on record along the frontier, one of few known to have […]
14 hours ago
Associated Press

Chipotle to pay NYC workers $20M for violating labor laws

NEW YORK (AP) — Chipotle Mexican Grill will pay $20 million to current and former workers at its New York City restaurants for violating city labor laws, Mayor Eric Adams announced Tuesday. According to investigators, Chipotle’s violations of the city’s Fair Workweek law included failing to post work schedules 14 days in advance, pay a […]
14 hours ago
Edward Barkovskaya walks along a bridge near an entrance to former President Donald Trump's Mar-a-L...
Associated Press

GOP rallies around Trump following FBI search of his estate

NEW YORK (AP) — For much of the year, small cracks in Donald Trump’s political support have been growing. Dissatisfied Republican primary voters began to consider new presidential prospects. GOP donors grappled with damaging revelations uncovered by the Jan. 6 committee. S everal party leaders pondered challenging Trump for the party’s 2024 nomination. But after […]
14 hours ago

Sponsored Articles

...
Carla Berg, MHS, Deputy Director, Public Health Services, Arizona Department of Health Services

Vaccines are safe if you are pregnant or breastfeeding

Are you pregnant? Do you have a friend or loved one who’s expecting?
...
CANVAS ANNUITY

Best retirement savings rates hit 4.30%

Maximize your retirement savings with guaranteed fixed rates up to 4.30%. Did you know there is a financial product that can give you great interest rates as you build your retirement savings and provide you with a paycheck for life once you retire? It might sound too good to be true but it is not; this product is called an annuity.
...
Carla Berg, MHS, Deputy Director, Public Health Services, Arizona Department of Health Services

Update your child’s vaccines before kindergarten

So, your little one starts kindergarten soon. How exciting! You still have a few months before the school year starts, so now’s the time to make sure students-to-be have the vaccines needed to stay safe as they head into a new chapter of life.
Pfizer asks US officials to OK promising COVID-19 pill